Company intelligence / Profile preview

Royal Biologics

Hackensack, New Jersey, United Statesroyalbiologics.com ↗
Ownership
Private
Employees
~27
Development stage
Commercial
01

Overview

Royal Biologics has launched several commercial products including the BIO‑REIGN™ line of bone graft substitutes. The company’s portfolio includes advanced cellular technologies and regenerative medicine platforms focused on musculoskeletal healing and wound care. Clinical results are not detailed publicly but the company emphasizes innovation in autologous cell-based therapies and proprietary biomaterials that support cell proliferation, vascularization, and new tissue growth.

Therapeutic areas
OtherDermatologyRheumatology
Modalities
Cell therapyBiologicDevicePolymer-based therapy
Industry
Therapeutic Medical Devices
02

Drug pipeline

3 assets

FIBRINET

Commercial
Indications
Lumbar fusion, Bone healing

2 more assets in the full pipeline.

Request access →
03

Partnerships

Licensing agreement with Molecular Matrix for Osteo-P® BGS technology underlying BIO‑REIGN™.

Beyond the preview

Go deeper on Royal Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royal Biologics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call